BioNTech Net Invested Capital from 2010 to 2024

BNTX Stock  USD 113.51  0.43  0.38%   
BioNTech Net Invested Capital yearly trend continues to be fairly stable with very little volatility. Net Invested Capital is likely to outpace its year average in 2024. Net Invested Capital is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. View All Fundamentals
 
Net Invested Capital  
First Reported
2010-12-31
Previous Quarter
20.5 B
Current Value
21.5 B
Quarterly Volatility
8.7 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioNTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioNTech's main balance sheet or income statement drivers, such as Tax Provision of 243 M, Net Interest Income of 367.2 M or Interest Income of 375.5 M, as well as many indicators such as Price To Sales Ratio of 5.69, Dividend Yield of 0.011 or PTB Ratio of 1.19. BioNTech financial statements analysis is a perfect complement when working with BioNTech Valuation or Volatility modules.
  
Check out the analysis of BioNTech Correlation against competitors.

Latest BioNTech's Net Invested Capital Growth Pattern

Below is the plot of the Net Invested Capital of BioNTech SE over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. BioNTech's Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioNTech's overall financial position and show how it may be relating to other accounts over time.
Net Invested Capital10 Years Trend
Slightly volatile
   Net Invested Capital   
       Timeline  

BioNTech Net Invested Capital Regression Statistics

Arithmetic Mean5,077,501,000
Geometric Mean388,287,621
Coefficient Of Variation171.02
Mean Deviation7,214,166,133
Median(49,296,000)
Standard Deviation8,683,290,305
Sample Variance75399530.5T
Range21.5B
R-Value0.79
Mean Square Error30378231.1T
R-Squared0.63
Significance0.0004
Slope1,536,085,496
Total Sum of Squares1055593427.3T

BioNTech Net Invested Capital History

202421.5 B
202320.5 B
202220.3 B
202112.2 B
20201.4 B
2019493.5 M
2018266.2 M

About BioNTech Financial Statements

BioNTech investors use historical fundamental indicators, such as BioNTech's Net Invested Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioNTech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Invested Capital20.5 B21.5 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.